- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 277/52 - Atomes d'azote liés à des hétéro-atomes à des atomes de soufre, p. ex. sulfamides
Détention brevets de la classe C07D 277/52
Brevets de cette classe: 119
Historique des publications depuis 10 ans
|
14
|
13
|
15
|
13
|
8
|
6
|
5
|
7
|
1
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Xenon Pharmaceuticals Inc. | 197 |
11 |
| Step Pharma S.A.S. | 36 |
9 |
| Merck Sharp & Dohme LLC | 3736 |
8 |
| Vertex Pharmaceuticals Incorporated | 1578 |
4 |
| Eastern Virginia Medical School | 64 |
3 |
| Genzyme Corporation | 1367 |
3 |
| The Regents of the University of California, Santa Cruz | 17 |
3 |
| Thomas Jefferson University | 555 |
3 |
| Nodthera Limited | 43 |
3 |
| Bristol-myers Squibb Company | 4751 |
2 |
| Amgen Inc. | 4429 |
2 |
| Board of Regents, The University of Texas System | 6117 |
2 |
| President and Fellows of Harvard College | 6092 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2304 |
2 |
| Beth Israel Deaconess Medical Center, Inc. | 850 |
2 |
| Dompé Farmaceutici S.p.A. | 298 |
2 |
| Elara Pharmaceuticals GmbH | 9 |
2 |
| European Molecular Biology Laboratory (embl) | 22 |
2 |
| Icagen, Inc. | 14 |
2 |
| IIT Research Institute | 8 |
2 |
| Autres propriétaires | 50 |